Clinical Trials

Lymphoma

NCT06923397 2026-04-13

Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial

24 enrolled

Phase 1 Not yet recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Sedentary Behavior

NCT07513129 2026-04-13

A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas

18 enrolled

BreastGastrointestinalGenitourinaryLymphoidThoracic

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04081779 2026-04-08

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Phase NA Completed

261 enrolled

Breast Neoplasms, Lung Neoplasms, Lymphoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT04300998 2026-04-07

Study of CAR-T Therapy in Older Patients

Recruiting

154 enrolled

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT04940468 2026-04-07

High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology

Phase NA Completed

8 enrolled

Clostridium Infections, Lymphoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07030699 2026-04-07

ECLAT

Phase 2 Withdrawn

Lymphoma

NCT07511426 2026-04-06

U96-CAR-T-Cells For R/R B-ALL

Phase 1 Recruiting

30 enrolled

Lymphoma, Recurrence, Leukemia, B-Cell

NCT02681302 2026-04-03

CPIT001

Phase 1/2 Terminated

46 enrolled 13 charts

Lymphoma, Multiple Myeloma

NCT05544968 2026-04-03

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Phase 1 Recruiting

42 enrolled

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT06692452 2026-04-01

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

NCT05763563 2026-03-31

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Phase NA Completed

20 enrolled

Leukemia, Lymphoma, Neoplasms, Plasma Cell

NCT07014293 2026-03-31

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Phase NA Not yet recruiting

254 enrolled

Lymphoma

NCT07290309 2026-03-31

SURGE

BreastGastrointestinalGynecologicLymphoidPlasma cell

300 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Motor Activity, Multiple Myeloma, Neoplasms, Ovarian Neoplasms

NCT07502872 2026-03-31

TPG

Phase 2 Not yet recruiting

30 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01177527 2026-03-30

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

Active not recruiting

656 enrolled

Smoldering Multiple Myeloma, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT03983668 2026-03-30

CMP-001 for Relapsed and Refractory Lymphoma

Phase 1/2 Terminated

14 enrolled 11 charts

Phase NA Not yet recruiting

Lymphoma

NCT07013435 2026-03-30

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

254 enrolled

Phase 2 Active not recruiting

Lymphoma

NCT03793140 2026-03-27

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

24 enrolled

Burkitt Lymphoma, Leukemia, Lymphoma

NCT05237245 2026-03-25

HTLV-OBS

Active not recruiting

69 enrolled

Leukemia, Lymphoma, HTLV-I Infections

NCT07226934 2026-03-25

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

40 enrolled

Communication, Lymphoma, Multiple Myeloma, Neoplasms

NCT07006012 2026-03-24

RGL-305+ Lymphoma + Exploratory Clinical Study

12 enrolled

LymphoidMyeloidOther hematologic neoplasm

Lymphoma

NCT05969821 2026-03-23

CHIS

Not yet recruiting

5,000 enrolled

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT01315132 2026-03-19

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Phase 2 Completed

47 enrolled 8 charts

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT07483749 2026-03-19

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

Not yet recruiting

400 enrolled